我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

中老年患者KLOTHO基因G-395A多态性与心力衰竭和心肌纤维化的相关性

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2015年第3期
页码:
278-282,297
栏目:
临床研究
出版日期:
2015-01-11

文章信息/Info

Title:
Correlation of polymorphisms of KLOTHO gene G-395A and heart failure and myocardial fibrosis in middle-aged and elderly patients
作者:
罗明雄1; 魏 玲2; 陈小丹1
（1.苏州市吴中人民医院心内科，江苏 苏州 215100；
2.成都军区昆明总医院老年重症救治中心，云南 昆明 650032）
Author(s):
LUO Ming-xiong1;  WEI Ling2;  CHEN Xiao-dan1
(1.Department of Cardiology, Wuzhong People’s Hospital, Suzhou 215100, Jiangsu, China；
2.ICU for Senior Patients, Kunming General Hospital, Chengdu Military Area Command, Kunming 650032, Yunnan, China)
关键词:
KLOTHO基因; 单核苷酸多态性; 心力衰竭; 心肌纤维化
Keywords:
KLOTHO gene;  single nucleotide polymorphisms;  heart failure;  myocardial fibrosis
分类号:
R541.6；R542.23
DOI:
-
文献标识码:
A
摘要:
目的:观察分析中老年患者KLOTHO基因G-395A多态性与心力衰竭(HF)和心肌纤维化的相关性。方法:随机选择无血缘关系的中老年患者212例, 提取外周血白细胞基因组DNA, 采用单一等位基因特异性引物PCR技术检测KLOTHO基因G-395A位点多态性，分析其在不同年龄组的分布是否有统计学意义；并把中老年患者分为HF组和非HF组，分析KLOTHO基因G-395A多态性与HF的相关性及与HF各严重程度分级的相关性；同时采用ELISA方法检测上述212例患者血液标本血清中Ⅰ型前胶原羧基端肽（PⅠCP）,Ⅲ型前胶原氨基端肽（PⅢNP）的浓度，分析KLOTHO基因G-395A多态性与心肌纤维化的相关性。结果:①G-395A位点存在多态性，出现3种基因型。②该位点基因型在中老年患者中频率分布总体上没有显著差异（χ2=12.159 P=0.121）；进一步分析各年龄组两两之间与基因型频率分布均无显著差异。③中老年患者KLOTHO基因G-395A多态性与HF发病危险性呈显著相关（χ2=23.634 P=0.00）；进一步分析显示AG是GG易患HF的1.991倍；AA是GG易患HF的1.527倍；GG可能对HF是保护因素。而与HF分级差异比较没有统计学意义（P=0.202）。④Ⅰ、Ⅲ型胶原浓度及Ⅰ/Ⅲ比值与中老年患者G-395A的3种基因型比较没有显著差异，与基因型不相关。结论:在中老年患者中， KLOTHO基因启动子区G-395A呈现3种多态性，这3种多态性与HF发病危险性呈显著相关, 携带A等位基因发生HF的危险性明显高于携带G等位基因的患者,GG可能对HF是保护因素；而与HF分级差异比较及与心肌纤维化程度比较没有统计学意义。
Abstract:
AIM:To analyze the correlation of polymorphisms of KLOTHO gene G-395A and heart failure and myocardial fibrosis in middle-aged and elderly patients. METHODS: Two hundred and twelve non-sanguineously related middle-aged and elderly patients were randomly selected and peripheral blood leucocyte genome DNA was extracted. KLOTHO gene G-395-A polymorphic loci were detected using the single allele-specific primer PCR technique and the statistical significance of the distribution in different age groups was analyzed. At the same time, the blood concentrations of serum I carboxy-terminal peptide of procollagen (PICP) and III procollagen amino-terminal peptide (PIIINP) were detected using ELISA. The correlation of KLOTHO gene G-395A polymorphisms with heart failure and myocardial fibrosis was analyzed. RESULTS: G-395-A polymorphism loci presented three genotypes. No significant difference was seen in the site of genotype frequency distribution in middle-aged and elderly patients (χ2=12.159 P=0.121). Further analysis between any two age groups and genotype frequency distribution found no significant difference. KLOTHO gene G-395-A polymorphism was significantly associated with heart disease risks in middle-aged and elderly patients (χ2 = 23.634 P=0.00). AG was found 1.991 times more susceptible to heart failure than GG and AA was 1.527 times more susceptible to heart failure than GG. GG might be a protective factor for heart failure. No statistical difference was found between heart failure classifications and myocardial fibrosis degrees (P=0.202). No significant difference was found in the concentrations of collagen type I and III and in I/III concentration ratios compared with the three genotypes of G-395-A in middle-aged and elderly patients and were not related to genotypes. CONCLUSION: In middle-aged and elderly patients, KLOTHO gene promoter region G-395-A presents three types of polymorphism and the three polymorphisms are all significantly associated with the onset of heart failure. The risk of heart failure in patients with A alleles is significantly higher than that in patients with G allele and GG may be a protective factor for heart failure. The difference between the classifications of heart failure and the degrees of myocardial fibrosis are not statistically significant.

参考文献/References

[1]Kuro-o M,Matsumura Y,Aizawa H,et al.Mutation of the mouse klotho gene leads to a syndrome resembling ageing[J].Nature,1997,390(6655):45-51.
[2]Minguell JJ,Erices A,Conget P.Mesenchynalstem cells[J].Exp BiolMedi,2001,226(6):507-520.
[3]Castro-Malaspina H,Gay RE,Resnick G,et al.Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny[J].Blood,1980,56(2):289-301.
[4]曹谊林,丁小邦.组织工程学理论与实践[M].上海:上海科学技术出版社,2005:10-12.
[5]马厚勋,牛永红,李章勇,等.等位基因特异性引物PCR技术及其应用研究[J].生物技术,2005,15(1):15-18.
[6]马厚勋,田小春,翟福利,等.汉族人群Klotho基因多态性及其与心动周期信号谱特征的相关性研究[J].重庆医科大学学报,2010,35(10):1457-1462.
[7]周 平,田小春,马厚勋,等.老年人群klotho G-395A、F352V与C370S基因多态性及组合与其血清klotho蛋白水平的相关性研究[J].重庆医科大学学报,2012,37(1):21-24.
[8]刘晓林,马厚勋,田小春,等.Klotho基因3个SNP位点与老年高血压及脂代谢的相关性[J].中国老年学杂志,2010,30(23):3429-3432.
[9]马厚勋,牛永红,李章勇,等.等位基因特异性引物PCR技术及其应用研究[J].生物技术,2005,15(1):15-18.
[10]Lammey ML,Baskin GB,Gigliotti AP,et al.Interstitial myocardial fibrosis in a captive chimpanzee (Pan troglodytes) population[J].Comp Med,2008,58(4):389-394.
[11]Baudino T,Carver W,Giles W,et al.Cardiac fibroblasts: friendor foe?[J].Am J Physiol Heart Circ Physiol,2006,291(3):H1015-H1026.
[12]Martos R,Baugh J,Ledwidge M,et al.Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction[J].Circulation,2007,115(7):888-895.
[13]Zeisberg M,Strutz F,Müller GA,et al.Role of fibroblast activation in inducing interstitial fibrosis[J].J Nephrol,2000,13(Suppl 3):S111-S120.
[14]Weber KT,Brilla CG,Janicki JS.Myocardial fibrosis: functional significance and regulatory factors[J].Cardiovasc Res,1993,27(3):341-348.
[15]Díez J,Laviades C,Mayor G,et al.Increased serum concentrations of procollagen peptides in essential hypertension. Relation to cardiac alterations[J].Circulation, 1995,91(5):1450-1456.

备注/Memo

备注/Memo:
收稿日期：2014-05-08.
作者简介：罗明雄,主治医师,硕士Email:lmx750104@163.com
更新日期/Last Update: 2015-02-03